IMPLICATIONS OF GHRELIN AXIS IN BREAST CANCER - REVIEW

被引:0
|
作者
Armasu, Ioana [1 ]
Volovat, C. [4 ]
Drug, V. L. [2 ]
Crumpei, Iulia [1 ]
Vasiliu, Ioana [1 ,3 ]
Tofan, Mariana
Preda, Cristina [1 ]
Serban, Ionela Lacramioara [3 ]
Vulpoi, Carmen [1 ]
机构
[1] Univ Med & Pharm Grigore T Popa Iasi, Fac Med, Dept Med Specialties 2, Iasi, Romania
[2] Univ Med & Pharm Grigore T Popa Iasi, Fac Med, Dept Med Specialties 1, Iasi, Romania
[3] Univ Med & Pharm Grigore T Popa Iasi, Fac Med, Dept Morpho Funct Sci, Iasi, Romania
[4] Victoria Hosp, Iasi, Romania
来源
关键词
GHRELIN; BREAST CANCER; NOVEL THERAPEUTIC TARGETS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Breast cancer is, by far, the most frequent cancer among women and many factors influence the physiological and pathological growth and development of the mammary gland. There is developing evidence that the hormone ghrelin, known for the growth hormone releasing effect and food intake modulator, could also play a role in the pathogenesis of breast cancer and may represent a new diagnostic marker and a potential therapeutic target. We performed a PubMed Database search of relevant studies and ten papers were included in our systematic review. Ghrelin axis seems to be definitely involved in the pathogenesis of breast cancer, although a precise role has not been yet established. In order to verify the precise role of ghrelin axis in breast cancer further studies with larger populations are necessary that should include the analysis of metabolic, genetic and environmental factors which are expected to influence the results.
引用
收藏
页码:302 / 309
页数:8
相关论文
共 50 条
  • [41] A Novel Human Ghrelin Variant (In1-Ghrelin) and Ghrelin-O-Acyltransferase Are Overexpressed in Breast Cancer: Potential Pathophysiological Relevance
    Gahete, Manuel D.
    Cordoba-Chacon, Jose
    Hergueta-Redondo, Marta
    Martinez-Fuentes, Antonio J.
    Kineman, Rhonda D.
    Moreno-Bueno, Gema
    Luque, Raul M.
    Castano, Justo P.
    PLOS ONE, 2011, 6 (08):
  • [42] IGF axis in breast cancer recurrence and metastasis
    Akhter, H.
    Bhowmik, M.
    Sultana, L.
    Mia, M.
    Rahman, S. H. Z.
    Akhtar, M. W.
    Tahmid, T.
    Faruque, M.
    Akter, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1266 - S1266
  • [43] The neurofibromin-lysosome axis in breast cancer
    Delicato, Antonella
    Millan, Pilar Chacon
    Duso, Bruno Achutti
    Castiglioni, Alessia
    Messuti, Eleonora
    Galavotti, Sara
    Medina, Diego
    Mazzarella, Luca
    Morleo, Manuela
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1241 - 1241
  • [44] The TSH/Thyroid Hormones Axis and Breast Cancer
    Voutsadakis, Ioannis A.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [45] Ghrelin's Role in the Hypothalamic-Pituitary-Adrenal Axis Stress Response: Implications for Mood Disorders
    Spencer, Sarah J.
    Emmerzaal, Tim L.
    Kozicz, Tamas
    Andrews, Zane B.
    BIOLOGICAL PSYCHIATRY, 2015, 78 (01) : 19 - 27
  • [46] Ghrelin Expression Is Associated with Favorable Outcome in Male Breast Cancer.
    Gronberg, M.
    Nilsson, C.
    Johansson, I.
    Hedenfalk, I.
    Janson, E. T.
    Fjallskog, M-L
    CANCER RESEARCH, 2011, 71
  • [47] Dutch digital breast cancer screening: implications for breast cancer care
    Timmers, Johanna M.
    den Heeten, Gerard J.
    Adang, Eddy M.
    Otten, Johannes D.
    Verbeek, Andre L.
    Broeders, Mireille J.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2012, 22 (06): : 925 - 929
  • [48] Ghrelin and cancer
    Chopin, Lisa
    Walpole, Carina
    Seim, Inge
    Cunningham, Peter
    Murray, Rachael
    Whiteside, Eliza
    Josh, Peter
    Herington, Adrian
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2011, 340 (01) : 65 - 69
  • [49] Ghrelin in gastrointestinal diseases and disorders: A possible role in the pathophysiology and clinical implications (Review)
    El-Salhy, Magdy
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (06) : 727 - 732
  • [50] The APE1/NPM1 axis in triple negative breast cancer: prognostic and therapeutic implications
    Malfatti, M. C.
    Gerratana, L.
    Di Loreto, C.
    Puglisi, F.
    Tell, G.
    ANNALS OF ONCOLOGY, 2017, 28